Protagonist Therapeutics Inc (PTGX)
26.59
-0.45
(-1.66%)
USD |
NASDAQ |
Apr 15, 16:00
26.63
+0.04
(+0.15%)
Pre-Market: 09:07
Protagonist Therapeutics Market Cap: 1.550B for April 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 15, 2024 | 1.550B |
| April 12, 2024 | 1.576B |
| April 11, 2024 | 1.612B |
| April 10, 2024 | 1.625B |
| April 09, 2024 | 1.698B |
| April 08, 2024 | 1.637B |
| April 05, 2024 | 1.632B |
| April 04, 2024 | 1.611B |
| April 03, 2024 | 1.636B |
| April 02, 2024 | 1.631B |
| April 01, 2024 | 1.648B |
| March 28, 2024 | 1.686B |
| March 27, 2024 | 1.660B |
| March 26, 2024 | 1.632B |
| March 25, 2024 | 1.625B |
| March 22, 2024 | 1.633B |
| March 21, 2024 | 1.652B |
| March 20, 2024 | 1.683B |
| March 19, 2024 | 1.679B |
| March 18, 2024 | 1.659B |
| March 15, 2024 | 1.689B |
| March 14, 2024 | 1.652B |
| March 13, 2024 | 1.760B |
| March 12, 2024 | 1.741B |
| March 11, 2024 | 1.755B |
| Date | Value |
|---|---|
| March 08, 2024 | 1.767B |
| March 07, 2024 | 1.800B |
| March 06, 2024 | 1.822B |
| March 05, 2024 | 1.804B |
| March 04, 2024 | 1.844B |
| March 01, 2024 | 1.874B |
| February 29, 2024 | 1.770B |
| February 28, 2024 | 1.773B |
| February 27, 2024 | 1.724B |
| February 26, 2024 | 1.721B |
| February 23, 2024 | 1.660B |
| February 22, 2024 | 1.614B |
| February 21, 2024 | 1.545B |
| February 20, 2024 | 1.571B |
| February 16, 2024 | 1.619B |
| February 15, 2024 | 1.629B |
| February 14, 2024 | 1.609B |
| February 13, 2024 | 1.558B |
| February 12, 2024 | 1.633B |
| February 09, 2024 | 1.540B |
| February 08, 2024 | 1.507B |
| February 07, 2024 | 1.466B |
| February 06, 2024 | 1.487B |
| February 05, 2024 | 1.501B |
| February 02, 2024 | 1.529B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
127.60M
Minimum
Dec 03 2019
2.363B
Maximum
Sep 01 2021
906.51M
Average
834.51M
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group Inc | 74.27M |
| Arvinas Inc | 2.363B |
| Akebia Therapeutics Inc | 291.03M |
| Immuneering Corp | 56.08M |
| Moderna Inc | 39.76B |
Market Cap Related Metrics
| Price to Book Value | 4.602 |
| Price | 26.59 |
| Earnings Yield | -5.60% |